HCG Manavata Cancer Centre
HCG Manavata Cancer Centre is a 275-bed NABH-accredited comprehensive cancer hospital in Nashik, Maharashtra, serving 2,50,000+ patients across surgical, medical, radiation, and nuclear medicine oncology, including international and home healthcare services.
- Company typePrivate
- Founded2007
- HeadquartersMumbai, India
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What HCG Manavata Cancer Centre does
HCG Manavata Cancer Centre is a 275-bed dedicated comprehensive cancer care hospital located in Nashik, Maharashtra, India, operating as HCG Manavata Oncology LLP under the Healthcare Global Enterprises Ltd. (HCG) parent network. Originally established as Curie Manavata Cancer Centre in 2007 by Dr. Raj Nagarkar, the centre has treated over 2,50,000 patients and performed more than 70,000 surgeries, including 1,300+ robotic-assisted procedures. It is the first NABH-accredited cancer hospital in Maharashtra and employs 54+ consultant oncologists and 900+ healthcare professionals across surgical, medical, radiation, nuclear medicine, and bone marrow transplant specialties.
HCG Manavata Cancer Centre firmographics
Firmographics- Name
- HCG Manavata Cancer Centre
- Legal name
- HCG Manavata Oncology LLP
- Website
- https://hcgmanavatacancer.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- HCG Manavata Cancer Centre is a 275-bed NABH-accredited comprehensive cancer hospital in Nashik, Maharashtra, serving 2,50,000+ patients across surgical, medical, radiation, and nuclear medicine oncology, including international and home healthcare services.
- Ownership category
- akta.pro rank
HCG Manavata Cancer Centre industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621)
- SIC
- Services-Hospitals (8060)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG), Medical Oncology (HLAKAFAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where HCG Manavata Cancer Centre is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
HCG Manavata Cancer Centre business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Medical Services Revenue: Revenue generated from comprehensive cancer care services including consultations, diagnostics, surgeries, chemotherapy, radiation therapy, nuclear medicine treatments, and inpatient care. Services are provided through multiple modalities including surgical oncology, medical oncology, radiation oncology, and bone marrow transplant.
- Diagnostic Services: Revenue from advanced diagnostic imaging services including PET-CT scans, MRI, CT scans, mammography, ultrasound, radiography, and laboratory tests. The centre performs 35,000+ PET CT scans.
- International Patient Services: Dedicated wing for international patients providing comprehensive cancer care with personalized services including coordination, accommodation assistance, and treatment planning.
- Home Healthcare Services: Extended and short infusions of chemotherapy and other treatments delivered at patient's home without compromising safety and treatment outcomes.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
HCG Manavata Cancer Centre product offering
Product offeringCore offering
HCG Manavata Cancer Centre is a 275-bed dedicated comprehensive cancer care hospital in Nashik, Maharashtra, providing integrated oncology services under one roof. The centre offers surgical oncology, medical oncology, radiation oncology, nuclear medicine, bone marrow transplant, robotic surgery, pathology, and radiodiagnosis, along with home healthcare, virtual consultation, and international patient services spanning prevention, screening, diagnosis, treatment, rehabilitation, and palliative care.
Product overview
HCG Manavata Cancer Centre is a single 275-bed comprehensive cancer care hospital offering integrated services across multiple treatment modalities. The center provides Medical Oncology, Surgical Oncology, Radiation Oncology, Bone Marrow Transplant, Nuclear Medicine, Pathology, and Radiodiagnosis services under one roof. Key technology offerings include the Versius Robotic Surgery System for minimally invasive procedures, Tomotherapy H and Versa HD for advanced radiation therapy, and PET-CT scanning for precise cancer diagnosis. The hospital also offers home healthcare, virtual consultations, and dedicated international patient services. Treatment approaches span chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and various surgical techniques including robotic, laparoscopic, and traditional open surgeries.
Differentiator
Problem solved
Functional benefit
Products and services
- HCG Manavata Cancer Centre Comprehensive Cancer Care A 275-bed dedicated comprehensive cancer care centre offering integrated services from prevention and screening through diagnosis, treatment, rehabilitation, and palliative care. The first NABH-accredited cancer hospital in Maharashtra serving general cancer patients of all ages.
- Surgical Oncology Services
Quantifiable outcome
- 2,50,000+ satisfied patients treated
- +5 more outcomes
Companies that use HCG Manavata Cancer Centre
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
HCG Manavata Cancer Centre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
HCG Manavata Cancer Centre partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- All Insurance ProviderscoreEmpaneled with all private and public-sector insurance providers, CGHS, ESIC, and ECHS schemes. This partnership enables patients to access treatment with reduced financial burden through insurance coverage.
- Maharashtra University of Health Sciences (MUHS)coreAcademic affiliation for postgraduate teaching programs. Accredited institution under National Board of Examinations, New Delhi for Surgical Oncology, Radiation Oncology, and Radiology training.
- National Board of Examinations, New DelhicoreAccredited for DNB programs in Surgical Oncology, Radiation Oncology, and Radiology specialties, enabling postgraduate medical education.
- KIMS Manavata HospitalscoreAffiliated hospital network under KIMS (Krishna Institute of Medical Sciences) for integrated healthcare delivery and academic programs.
- HealthCare Global Enterprises Ltd.coreParent company HCG operates a network of cancer hospitals across India, providing brand, operational support, and clinical protocols.
Scale indicators11 records
Recent moves9 records
Expansion highlights5 records
HCG Manavata Cancer Centre competitors and assessment
Company assessmentDirect peers
- Cytecare Cancer Hospital: Bengaluru-based specialty cancer hospital offering comprehensive oncology services similar to Manavata. Direct peer in terms of a standalone dedicated cancer hospital model with surgical, medical and radiation modalities under one roof.
- HCG (Healthcare Global Enterprises) Network Centres: The parent HCG network operates multiple cancer hospitals across India (Bangalore, Ahmedabad, etc.) using the same protocols, brand and technology stack as Manavata. Directly comparable in service mix, with HCG's national brand providing counter-positioning pressure on the standalone Nashik centre.
- Tata Memorial Hospital: India's flagship tertiary cancer centre in Mumbai offering comprehensive surgical, medical, and radiation oncology. Direct peer because it sets the clinical benchmark and referral destination for complex oncology in Maharashtra, competing with HCG Manavata for the same patient base willing to travel from Nashik.
- American Oncology Institute: India-based chain of dedicated cancer hospitals (Hyderabad, Nagpur, etc.) backed by US Oncology Network. Direct peer operating in the same specialty-oncology-only model with radiation, medical and surgical oncology across Tier-2 cities, competing for similar uninsured/self-pay patient segments.
Broad incumbents
- Apollo Cancer Centres: Apollo Hospitals' specialty oncology division running comprehensive cancer care including robotic surgery, radiation, and BMT across multiple Indian metros. Broad incumbent offering overlapping oncology capabilities within a much larger national footprint.
- Fortis Hospital (Oncology): Fortis Healthcare operates large multi-specialty hospitals in metros (Mumbai, Bangalore, Delhi) with established oncology programmes including radiation, surgical and medical oncology. Broad incumbent with overlapping clinical capabilities at larger catchment scale.
- Manipal Hospital (Oncology): Manipal Hospitals operates a pan-India multi-specialty chain with established oncology programmes in metros and tier-1 cities. Broad incumbent offering overlapping cancer care services and competing for cross-state referrals.
Regional players
- Ruby Hall Clinic: Pune-based multi-specialty tertiary hospital with a recognised cancer care programme serving Western Maharashtra. Regional player providing comparable oncology services within driving distance of Manavata's catchment.
- Sahyadri Hospitals: Western India's largest hospital chain with strong presence in Pune/Nashik region, offering oncology among other specialties. Regional player that competes directly with Manavata for North Maharashtra cancer patients seeking treatment closer to home.
- Kolhapur Cancer Centre: A specialty cancer hospital in Western Maharashtra offering surgical, medical and radiation oncology in a tier-2/3 city setting. Direct regional peer in scope, scale and catchment, providing a benchmark for HCG Manavata in similar markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
HCG Manavata Cancer Centre social profiles
Digital presenceHCG Manavata Cancer Centre compliance and trust
Trust signalCompliance2 records
HCG Manavata Cancer Centre financial estimates
Financial estimateRevenue estimate
Valuation estimate
HCG Manavata Cancer Centre leadership team
Management profileNumber of profiles
Profiles11 records
HCG Manavata Cancer Centre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HCG Manavata Cancer Centre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HCG Manavata Cancer Centre
What does HCG Manavata Cancer Centre do?
HCG Manavata Cancer Centre is a 275-bed dedicated comprehensive cancer care hospital in Nashik, Maharashtra, providing integrated oncology services under one roof. The centre offers surgical oncology, medical oncology, radiation oncology, nuclear medicine, bone marrow transplant, robotic surgery, pathology, and radiodiagnosis, along with home healthcare, virtual consultation, and international patient services spanning prevention, screening, diagnosis, treatment, rehabilitation, and palliative care.
Is HCG Manavata Cancer Centre a public or private company?
HCG Manavata Cancer Centre is a private company. It is classified as corporate owned and is currently operating.
When was HCG Manavata Cancer Centre founded?
HCG Manavata Cancer Centre was founded in 2007. It employs 501 to 1,000 people.
Where is HCG Manavata Cancer Centre based?
HCG Manavata Cancer Centre is headquartered in Mumbai, India, in the Asia region.
How does HCG Manavata Cancer Centre make money?
Four revenue lines are on record. Medical Services Revenue is the primary driver. The others are diagnostic Services, international Patient Services and home Healthcare Services.
Who are HCG Manavata Cancer Centre's main competitors?
Direct peers on record are Cytecare Cancer Hospital, HCG (Healthcare Global Enterprises) Network Centres, Tata Memorial Hospital and American Oncology Institute. Broad incumbents are Apollo Cancer Centres, Fortis Hospital (Oncology) and Manipal Hospital (Oncology). Regional players are Ruby Hall Clinic, Sahyadri Hospitals and Kolhapur Cancer Centre.
Does HCG Manavata Cancer Centre have an API?
No public API is recorded for HCG Manavata Cancer Centre.
What industry is HCG Manavata Cancer Centre in?
HCG Manavata Cancer Centre's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.